Delivery Order SPE2DB20D3505-SPE2DB23FT4N9
- Not listed
- This federal contract award, valued at $3,990.57, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of Emtricitabine-Tenofv 200-300mg pharmaceutical products, a critical medication for various medical treatments. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00, which serves as the primary vehicle for...
- This federal contract award, valued at $4,034.75, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for the supply of Emtricitabine-Tenofv 200-300mg medication. This award is part of a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora, Inc., with the DLA Troop Support Medical, valued at up to...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,002.56 firm fixed-price delivery order is for the supply of Emtricitabine-Tenofovir 200-300mg prescription medication. The award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora, Inc., with the DLA Troop Support Medical. This IDC serves as the...
- This federal contract award, valued at $1,389.06, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of emtricitabine-tenofovir 200-300mg pharmaceutical products. The award is a delivery order under a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999.00 and running through November 2026. This IDC serves as the primary vehicle for Amerisourcebergen...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $3,178.59 firm fixed-price delivery order covers the supply of 4556164153 units of Emtricitabine-Tenofovir 200-300 mg tablets. This contract is not designated with a set-aside requirement, indicating open competition. Amerisourcebergen Drug Corp holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
- This federal contract award is a delivery order issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of Emtricitabine-Tenofv 200-300 mg medication. The award has a ceiling value of $1,399.07 and a completion date of November 13, 2023. The contract is a firm fixed-price delivery order, without any set-aside designation. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a Delivery Order (Contract SPE2DB22FL4C6) valued at $2,837.42. The contract is with the Defense Logistics Agency (DLA) for the delivery of pharmaceutical products, including the antiretroviral medication emtricitabine-tenofv. This Delivery Order is part of a larger Indefinite Delivery Contract (IDC) that Cencora, Inc. holds with the DLA Troop Support Medical, valued at up to $999,999,999.00 and...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,262.63 firm-fixed-price delivery order is for the supply of emtricitabine-tenofovir 200-300 mg prescription medications. The contract has a completion date of February 2, 2022 and was awarded on February 1, 2022. This delivery order is part of a larger Indefinite Delivery Contract (IDC) held by...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of pharmaceutical products, including emtricitabine-tenofovir 200-300 mg tablets, with a ceiling value of $1,062.10. It is a firm fixed-price delivery order contract with a period of performance ending on May 3, 2023. The contract is not set aside for any specific business type. It is part of a larger Indefinite Delivery...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of 4557488948 units of the medication Emtricitabine-Tenofv 200-300mg. The firm-fixed-price delivery order, valued at $2,338.12, has a completion date of June 10, 2022. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which is registered in the System for Award Management (SAM.gov) through January 2026....
- SPE2DB20D3505Indefinite Delivery Contract
- SPE2DB20D3505-SPE2DB23FT4N9Delivery Order
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the pharmaceutical distribution company Cencora, Inc. The $1,423.46 firm fixed-price delivery order covers the supply of 4,559,445,928 units of the pharmaceutical product Emtricitabine-Tenofv 200-300mg. This delivery order is part of a larger $999,999,999.00 Indefinite Delivery Contract (IDC) held by Cencora, Inc. with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract does not have a set-aside designation, indicating it was awarded through full and open competition.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.4k | 12/22/22 |